Medical Journals

Induction of T-cell Response by a Dna Vaccine Encoding a Novel Hla-a*0201 Severe Acute Respiratory Syndrome Coronavirus Epitope.

Authors:
  • Cheung Ying-Kit
  • Cheng Samuel Chak-Sum
  • Sin Fion Wan-Yee
  • Chan Kin-Tak
  • Xie Yong

From: Department of Biology, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR, China.

Vaccine

  • Publish Date: Aug 2007
  • ISSN: 0264-410X
  • Volume: 25
  • Issue: 32
  • Pages: 6070-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cheung Ying-Kit, Cheng Samuel Chak-Sum, Sin Fion Wan-Yee, et al. Induction of T-cell Response by a Dna Vaccine Encoding a Novel Hla-a*0201 Severe Acute Respiratory Syndrome Coronavirus Epitope.. Vaccine Aug 2007;25:6070-7

Abstract

The severe acute respiratory syndrome coronavirus nucleocapsid protein (SARS-CoV N) is one of the major targets for SARS vaccine due to its high potency in triggering immune responses. In this study, we have identified a novel HLA-A*0201 restricted epitope, N220 (LALLLLDRL), of the SARS-CoV N-protein through bioinformatics analysis. The N-protein peptide N220 shows a high binding affinity towards human MHC class I in T2-cells, and is capable of activating cytotoxic T-cells in human peripheral blood mononuclear cells (PBMCs). The application of using the N220 peptide sequence with a single-chain-trimer (SCT) approach to produce a potential DNA vaccine candidate was investigated in HLA-A2.1K(b) transgenic mice. Cytotoxicity assay clearly showed that the T-cells obtained from the vaccinated animals were able to kill the N-protein expressing cells with a cytotoxicity level of 86% in an effector cells/target cells ratio of 81:1 one week after the last vaccination, which is significantly higher than other N-protein peptides previously described. The novel immunogenic N-protein peptide revealed in the present study provides valuable information for therapeutic SARS vaccine design.

Mesh Headings (Keywords): Animals, CD8-Positive T-Lymphocytes, Cell Line, Epitopes, T-Lymphocyte, HLA-A Antigens, Humans, Mice, Mice, Transgenic, Nucleocapsid Proteins, SARS Virus, Severe Acute Respiratory Syndrome, T-Lymphocytes, T-Lymphocytes, Cytotoxic, Vaccines, DNA, Viral Vaccines


Check for Full Text / PubMed Unique Identifier (PMID): 17629360


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.